Hasil Pencarian - Jochen Utikal

Perbaiki Hasil
  1. 1
    Stem Cell-Derived Models of Neural Crest Are Essential to Understand Melanoma Progression and Therapy Resistance

    Stem Cell-Derived Models of Neural Crest Are Essential to Understand Melanoma Progression and Therapy Resistance oleh Lionel Larribère, Lionel Larribère, Jochen Utikal, Jochen Utikal

    Diterbitkan 2019-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Melanoma Cellular Plasticity

    Melanoma Cellular Plasticity oleh Daniel Novak, Jochen Utikal

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    SOX2 and cancer: current research and its implications in the clinic

    SOX2 and cancer: current research and its implications in the clinic oleh Kasia Weina, Jochen Utikal

    Diterbitkan 2014-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Tackling malignant melanoma epigenetically: histone lysine methylation

    Tackling malignant melanoma epigenetically: histone lysine methylation oleh Elias Orouji, Jochen Utikal

    Diterbitkan 2018-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Cellular Reprogramming—A Model for Melanoma Cellular Plasticity

    Cellular Reprogramming—A Model for Melanoma Cellular Plasticity oleh Karol Granados, Juliane Poelchen, Daniel Novak, Jochen Utikal

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression

    The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression oleh Viktor Umansky, Carolin Blattner, Christoffer Gebhardt, Jochen Utikal

    Diterbitkan 2016-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Chromosome 7 Aneusomy. A Marker for Metastatic Melanoma?

    Chromosome 7 Aneusomy. A Marker for Metastatic Melanoma? oleh Martin Udart, Jochen Utikal, Gertraud M. Krähn, Ralf U. Peter

    Diterbitkan 2001-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies?

    Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies? oleh Fabrice Tolle, Viktor Umansky, Jochen Utikal, Stephanie Kreis, Sabrina Bréchard

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients

    Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients oleh Vera Petrova, Vera Petrova, Vera Petrova, Vera Petrova, Christopher Groth, Christopher Groth, Christopher Groth, Christopher Groth, Rebekka Bitsch, Rebekka Bitsch, Rebekka Bitsch, Rebekka Bitsch, Ihor Arkhypov, Ihor Arkhypov, Ihor Arkhypov, Ihor Arkhypov, Sonja C. S. Simon, Svetlana Hetjens, Verena Müller, Jochen Utikal, Jochen Utikal, Jochen Utikal, Jochen Utikal, Viktor Umansky, Viktor Umansky, Viktor Umansky, Viktor Umansky

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target

    Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target oleh Feyza Gul Ozbay Kurt, Samantha Lasser, Ihor Arkhypov, Jochen Utikal, Viktor Umansky

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic Niches

    Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic Niches oleh Alice Pievani, Roberto Savoldelli, Roberto Savoldelli, Juliane Poelchen, Juliane Poelchen, Elisa Mattioli, Elisa Mattioli, Giorgio Anselmi, Alice Girardot, Jochen Utikal, Jochen Utikal, Pierre Bourdely, Marta Serafini, Pierre Guermonprez

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma

    Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma oleh Vera Petrova, Ihor Arkhypov, Rebekka Weber, Christopher Groth, Peter Altevogt, Jochen Utikal, Viktor Umansky

    Diterbitkan 2020-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression

    Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression oleh Viktor Fleming, Viktor Fleming, Xiaoying Hu, Xiaoying Hu, Rebekka Weber, Rebekka Weber, Vasyl Nagibin, Vasyl Nagibin, Christopher Groth, Christopher Groth, Peter Altevogt, Peter Altevogt, Jochen Utikal, Jochen Utikal, Viktor Umansky, Viktor Umansky

    Diterbitkan 2018-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma

    Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma oleh Johanna Matull, Johanna Matull, Jan-Malte Placke, Georg Lodde, Anne Zaremba, Jochen Utikal, Jochen Utikal, Jochen Utikal, Patrick Terheyden, Claudia Pföhler, Rudolf Herbst, Alexander Kreuter, Julia Welzel, Julia Kretz, Inga Möller, Antje Sucker, Annette Paschen, Elisabeth Livingstone, Lisa Zimmer, Eva Hadaschik, Selma Ugurel, Dirk Schadendorf, Dirk Schadendorf, Dirk Schadendorf, Carl Maximilian Thielmann, Klaus Georg Griewank

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs

    Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs oleh Alisa Lepper, Rebekka Bitsch, Feyza Gül Özbay Kurt, Ihor Arkhypov, Samantha Lasser, Jochen Utikal, Viktor Umansky

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles

    Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles oleh Ihor Arkhypov, Samantha Lasser, Vera Petrova, Rebekka Weber, Christopher Groth, Jochen Utikal, Peter Altevogt, Viktor Umansky

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors

    Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors oleh Rebekka Weber, Rebekka Weber, Rebekka Weber, Viktor Fleming, Viktor Fleming, Viktor Fleming, Xiaoying Hu, Xiaoying Hu, Vasyl Nagibin, Vasyl Nagibin, Christopher Groth, Christopher Groth, Peter Altevogt, Peter Altevogt, Jochen Utikal, Jochen Utikal, Viktor Umansky, Viktor Umansky

    Diterbitkan 2018-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma

    Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma oleh Aniello Federico, Tamara Steinfass, Lionel Larribère, Daniel Novak, Francisco Morís, Luz-Elena Núñez, Viktor Umansky, Jochen Utikal

    Diterbitkan 2020-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm

    Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm oleh Neta Tsur, Yuri Kogan, Evgenia Avizov-Khodak, Désirée Vaeth, Nils Vogler, Jochen Utikal, Michal Lotem, Zvia Agur

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2

    Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2 oleh Feyza Gül Özbay Kurt, Feyza Gül Özbay Kurt, Feyza Gül Özbay Kurt, Feyza Gül Özbay Kurt, Alisa Lepper, Alisa Lepper, Alisa Lepper, Alisa Lepper, Catharina Gerhards, Mathis Roemer, Samantha Lasser, Samantha Lasser, Samantha Lasser, Samantha Lasser, Ihor Arkhypov, Ihor Arkhypov, Ihor Arkhypov, Ihor Arkhypov, Rebekka Bitsch, Rebekka Bitsch, Rebekka Bitsch, Rebekka Bitsch, Peter Bugert, Peter Altevogt, Peter Altevogt, Peter Altevogt, Peter Altevogt, Cécile Gouttefangeas, Michael Neumaier, Jochen Utikal, Jochen Utikal, Jochen Utikal, Jochen Utikal, Viktor Umansky, Viktor Umansky, Viktor Umansky, Viktor Umansky

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: